Ruud P.M. Dings

Ruud P.M. Dings is an Assistant Professor in the Department of Radiation Oncology at the University of Arkansas for Medical Sciences (UAMS), College of Medicine. His research focuses on enhancing cancer treatment through understanding tumor biology, with emphasis on drug discovery, tumor microenvironment, and glycobiology.

His educational background includes:

• M.Sc. from University of Maastricht, Maastricht, The Netherlands
• Ph.D. from University of Maastricht, Maastricht, The Netherlands
• Postdoctoral fellowship at University of Minnesota, Minneapolis

Dr. Dings' primary research interests lie in cancer biology and translational oncology. He investigates drug discovery and development for cancer treatment, focusing on the tumor microenvironment including vessel normalization and immunology. His work also explores cancer glycobiology, particularly galectins, and optimizing conventional treatments through novel combinations and mechanisms. The overarching goal is to contribute to improved cancer therapies and clinical practice.

His recent publications demonstrate a consistent focus on angiogenesis inhibition and tumor microenvironment modulation. Key themes include the development of novel drug delivery systems, such as plasmonically active nanodrugs for triple-negative breast cancer, and the role of galectin-1 in tumor angiogenesis. His work often combines radiation therapy with anti-angiogenic agents to enhance therapeutic outcomes, reflecting a translational approach from basic science to preclinical models.

Scientific Awards: None mentioned in the source text.

There is no information provided about students advised or research grants received.

Dr. Dings leads an active research laboratory focused on cancer biology and translational research, with ongoing projects in drug development, tumor microenvironment, and nanomedicine for cancer therapy.